These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34416114)

  • 1. Neuropsychiatric Symptoms in Patients With Alzheimer's Disease During SARS-COV-2 Pandemic in Peru.
    Custodio N; Castro-Suárez S; Montesinos R; Failoc-Rojas VE; Cruz Del Castillo R; Herrera-Perez E
    Am J Alzheimers Dis Other Demen; 2021; 36():15333175211039089. PubMed ID: 34416114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 Mandatory Lockdown Measures on Cognitive and Neuropsychiatric Symptoms in Persons with Alzheimer's Disease in Lima, Peru.
    Custodio N; Malaga M; Montesinos R; Chambergo D; Baca F; Castro S; Carbajal JC; Herrera E; Lira D; Diaz MM; Lanata S
    Curr Alzheimer Res; 2023; 20(2):80-88. PubMed ID: 37073648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer's disease during the COVID-19 lockdown.
    Lara B; Carnes A; Dakterzada F; Benitez I; Piñol-Ripoll G
    Eur J Neurol; 2020 Sep; 27(9):1744-1747. PubMed ID: 32449791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and Alzheimer's disease: Impact of lockdown and other restrictive measures during the COVID-19 pandemic.
    Nawaz AD; Haider MZ; Akhtar S
    Biomol Biomed; 2024 Mar; 24(2):219-229. PubMed ID: 38078809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of COVID-19 pandemic on elderly with neurocognitive disorders.
    Basta M; Skourti E
    Psychiatriki; 2023 Oct; 34(3):177-180. PubMed ID: 37449850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropsychiatric symptoms in people living with dementia related to COVID-19 pandemic lockdown. Exploratory systematic review].
    Sánchez-García M; Rodríguez-Del Rey T; Pérez-Sáez E; Gay-Puente FJ
    Rev Neurol; 2022 Feb; 74(3):83-92. PubMed ID: 35084733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis.
    Boutoleau-Bretonnière C; Pouclet-Courtemanche H; Gillet A; Bernard A; Deruet AL; Gouraud I; Mazoue A; Lamy E; Rocher L; Kapogiannis D; El Haj M
    J Alzheimers Dis; 2020; 76(1):41-47. PubMed ID: 32568211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
    Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of physical activity during the COVID-19 pandemic is related to increased neuropsychiatric symptoms in memory clinic patients.
    Wurm R; Parvizi T; Silvaeih S; Berger-Sieczkowski E; Goeschl S; König T; Lehrner J; Stögmann E
    Clin Med (Lond); 2022 Mar; 22(2):177-180. PubMed ID: 35190387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
    Hallikainen I; Hongisto K; Välimäki T; Hänninen T; Martikainen J; Koivisto AM
    J Alzheimers Dis; 2018; 61(4):1367-1376. PubMed ID: 29376861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frailty, psychological well-being, and social isolation in older adults with cognitive impairment during the SARS-CoV-2 pandemic: data from the GeroCovid initiative.
    Terziotti C; Ceolin C; Devita M; Raffaelli C; Antenucci S; Bazzano S; Capasso A; Castellino M; Signore SD; Lubian F; Maiotti M; Monacelli F; Mormile MT; Sgarito C; Vella F; Sergi G; Gareri P; Trevisan C; Bellio A; Fini F; Malara A; Mossello E; Fumagalli S; Volpato S; Monzani F; Bellelli G; Zia G; Incalzi RA; Coin A
    Psychogeriatrics; 2023 Nov; 23(6):1007-1018. PubMed ID: 37679953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric Symptoms in Alzheimer's Disease Are the Main Determinants of Functional Impairment in Advanced Everyday Activities.
    Delgado C; Vergara RC; Martínez M; Musa G; Henríquez F; Slachevsky A
    J Alzheimers Dis; 2019; 67(1):381-392. PubMed ID: 30584142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of lockdown during SARS-CoV-2 outbreak on behavioral and psychological symptoms of dementia.
    Manini A; Brambilla M; Maggiore L; Pomati S; Pantoni L
    Neurol Sci; 2021 Mar; 42(3):825-833. PubMed ID: 33442845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of COVID-19 Pandemic Confinement in Patients With Cognitive Impairment.
    Barguilla A; Fernández-Lebrero A; Estragués-Gázquez I; García-Escobar G; Navalpotro-Gómez I; Manero RM; Puente-Periz V; Roquer J; Puig-Pijoan A
    Front Neurol; 2020; 11():589901. PubMed ID: 33329337
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress.
    Fonseca LM; Mattar GP; Haddad GG; Burduli E; McPherson SM; Guilhoto LMFF; Yassuda MS; Busatto GF; Bottino CMC; Hoexter MQ; Chaytor NS
    J Alzheimers Dis; 2021; 81(1):137-154. PubMed ID: 33749644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic.
    Borelli WV; Augustin MC; de Oliveira PBF; Reggiani LC; Bandeira-de-Mello RG; Schumacher-Schuh AF; Chaves MLF; Castilhos RM
    J Alzheimers Dis; 2021; 80(4):1705-1712. PubMed ID: 33646168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural and psychological symptoms of dementia in patients with Alzheimer's disease and family caregiver burden: a path analysis.
    Kim B; Noh GO; Kim K
    BMC Geriatr; 2021 Mar; 21(1):160. PubMed ID: 33663416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.
    Kaufer DI; Cummings JL; Christine D; Bray T; Castellon S; Masterman D; MacMillan A; Ketchel P; DeKosky ST
    J Am Geriatr Soc; 1998 Feb; 46(2):210-5. PubMed ID: 9475452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.